The ability to maintain a state of controlled inflammation is a feature unique to the gut associated lymphoid tissue. We have identified a novel cell in the regulation of this state. the normal intestinal enterocyte. This cell is fully capable of engulfing antigen, processing it and presenting the resultant immunogenic peptides to antigen primed T cells. However, in contrast to conventional antigen presenting cells, epithelial cells of the gut appear to selectively stimulate antigen non-specific suppressor T cells. We have identified the essential parameters of antigen presenting cell function in these cells over the past two years, including the finding that these cells stimulate suppressor T cells. In the next period, we propose to carefully dissect out mechanisms of CD8+ T cell stimulation. Our current data suggest that a novel CD8 ligand might exist on normal enterocytes but that aberrant processing, of antigen may also play a role in specific T cell activation. We purpose studies to identify a novel CD8 ligand by monoclonal antibody technology, isolation of potential ligands, and determination of CD8 binding and potential signal transduction pathways using the src-like tyrosine protein kinase, p56lck. In addition, we will seek to determine whether antigen uptake and processing is a physiologic event in the normal GI tract, by assessing, uptake and processing events by following, labelled proteins into the cell and through the degradative endolysosomal pathways, using fluoresceinated and radiolabelled proteins. In this manner, we will develop a better understanding of the normal mechanisms for antigen handling, in the intestine and add insights into disease processes, where antigen handling, may be aberrant.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI023504-04A1
Application #
3135704
Study Section
Immunological Sciences Study Section (IMS)
Project Start
1986-09-01
Project End
1994-08-31
Budget Start
1991-09-30
Budget End
1992-08-31
Support Year
4
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10029
Rabinowitz, Keren M; Wang, Yuanyuan; Chen, Edward Y et al. (2013) Transforming growth factor ? signaling controls activities of human intestinal CD8(+)T suppressor cells. Gastroenterology 144:601-612.e1
Roda, Giulia; Dahan, Stephanie; Mezzanotte, Laura et al. (2009) Defect in CEACAM family member expression in Crohn's disease IECs is regulated by the transcription factor SOX9. Inflamm Bowel Dis 15:1775-83
Roth-Walter, F; Berin, M C; Arnaboldi, P et al. (2008) Pasteurization of milk proteins promotes allergic sensitization by enhancing uptake through Peyer's patches. Allergy 63:882-90
Dahan, Stephanie; Roda, Giulia; Pinn, David et al. (2008) Epithelial: lamina propria lymphocyte interactions promote epithelial cell differentiation. Gastroenterology 134:192-203
Bogunovic, Milena; Dave, Shaival H; Tilstra, Jeremy S et al. (2007) Enteroendocrine cells express functional Toll-like receptors. Am J Physiol Gastrointest Liver Physiol 292:G1770-83
Perera, Lilani; Shao, Ling; Patel, Anjlee et al. (2007) Expression of nonclassical class I molecules by intestinal epithelial cells. Inflamm Bowel Dis 13:298-307
Dotan, Iris; Allez, Matthieu; Nakazawa, Atsushi et al. (2007) Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-gamma. Am J Physiol Gastrointest Liver Physiol 292:G1630-40
Kraus, Thomas A; Cheifetz, Adam; Toy, Lisa et al. (2006) Evidence for a genetic defect in oral tolerance induction in inflammatory bowel disease. Inflamm Bowel Dis 12:82-8; discussion 81
Shao, Ling; Jacobs, Adam R; Johnson, Valrie V et al. (2005) Activation of CD8+ regulatory T cells by human placental trophoblasts. J Immunol 174:7539-47
Brimnes, Jens; Allez, Matthieu; Dotan, Iris et al. (2005) Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease. J Immunol 174:5814-22

Showing the most recent 10 out of 85 publications